GATA3 and in situ carcinoma: Among CD4+ T cells, the percentage of GATA3+FOXP3– cells and the percentage of GATA3+FOXP3+ cells were higher in invasive melanoma compared with in situ melanoma, while the percentage of GATA3–FOXP3+ cells remained similar (Figure 8C).